메뉴 건너뛰기




Volumn 20, Issue 2, 2017, Pages 200-205

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Author keywords

convergent validity; inter rater reliability; oncology; value frameworks

Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG;

EID: 85011954091     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2016.12.011     Document Type: Article
Times cited : (38)

References (26)
  • 1
    • 85013588981 scopus 로고    scopus 로고
    • 42 CFR part 511 Medicare program; part B drug payment model; proposed rule
    • [1] Centers for Medicare & Medicaid Services. 42 CFR part 511 Medicare program; part B drug payment model; proposed rule. Fed Regist 48 (2016), 13230–13261.
    • (2016) Fed Regist , vol.48 , pp. 13230-13261
  • 2
    • 84940648261 scopus 로고    scopus 로고
    • A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
    • [2] Cherny, N.I., Sullivan, R., Dafni, U., et al. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). Ann Oncol 26 (2015), 1547–1573.
    • (2015) Ann Oncol , vol.26 , pp. 1547-1573
    • Cherny, N.I.1    Sullivan, R.2    Dafni, U.3
  • 3
    • 84939251874 scopus 로고    scopus 로고
    • American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
    • [3] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33 (2015), 2563–2577.
    • (2015) J Clin Oncol , vol.33 , pp. 2563-2577
    • Schnipper, L.E.1    Davidson, N.E.2    Wollins, D.S.3
  • 4
    • 84976398620 scopus 로고    scopus 로고
    • Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received
    • [4] Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 34 (2016), 2925–2934.
    • (2016) J Clin Oncol , vol.34 , pp. 2925-2934
    • Schnipper, L.E.1    Davidson, N.E.2    Wollins, D.S.3
  • 5
    • 85013571531 scopus 로고    scopus 로고
    • TM frequently asked questions. Available from: [Accessed August 24, ].
    • TM frequently asked questions. Available from: https://www.nccn.org/evidenceblocks/pdf/EvidenceBlocksFAQ.pdf. [Accessed August 24, 2016].
    • (2016)
  • 6
    • 85013613860 scopus 로고    scopus 로고
    • TM user guide. Available from: [Accessed August 24, ].
    • TM user guide. Available from: https://www.nccn.org/evidenceblocks/pdf/EvidenceBlocksUserGuide.pdf. [Accessed August 24, 2016].
    • (2016)
  • 7
    • 85013577204 scopus 로고    scopus 로고
    • Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks
    • Institute for Clinical and Economic Review Boston, MA
    • [7] Ollendorf, D., Chapman, R., Khan, S., et al. Treatment Options for Relapsed or Refractory Multiple Myeloma: Effectiveness, Value, and Value-Based Price Benchmarks. 2016, Institute for Clinical and Economic Review, Boston, MA.
    • (2016)
    • Ollendorf, D.1    Chapman, R.2    Khan, S.3
  • 8
    • 85013608744 scopus 로고    scopus 로고
    • NCCN clinical practice guidelines in oncology (NCCN guidelines) with NCCN Evidence Blocks. Available from: [Accessed August 25, ].
    • [8] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines) with NCCN Evidence Blocks. Available from: https://www.nccn.org/evidenceblocks/. [Accessed August 25, 2016].
    • (2016)
  • 9
    • 84977500588 scopus 로고    scopus 로고
    • ICER evidence rating matrix: a user's guide
    • 2016. Available from: [Accessed June 15,].
    • [9] Ollendorf D, Pearson SD. ICER evidence rating matrix: a user's guide. 2016. Available from: http://icer-review.org/wp-content/uploads/2016/01/Rating-Matrix-User-Guide-FINAL-v10-22-13.pdf. [Accessed June 15, 2016].
    • (2016)
    • Ollendorf, D.1    Pearson, S.D.2
  • 10
    • 85013604617 scopus 로고    scopus 로고
    • Addressing the myths about ICER and value assessment. Available from: [Accessed August 10, ].
    • [10] Institute for Clinical and Economic Review. Addressing the myths about ICER and value assessment. Available from: https://icer-review.org/myths/. [Accessed August 10, 2016].
    • (2016)
  • 11
    • 84969262222 scopus 로고    scopus 로고
    • Toward a patient-centered value framework in oncology
    • [11] Basch, E., Toward a patient-centered value framework in oncology. JAMA, 315, 2016, 2073.
    • (2016) JAMA , vol.315 , pp. 2073
    • Basch, E.1
  • 12
    • 84969195206 scopus 로고    scopus 로고
    • Utility of cancer value frameworks for patients, payers, and physicians
    • [12] Chandra, A., Shafrin, J., Dhawan, R., Utility of cancer value frameworks for patients, payers, and physicians. JAMA, 315, 2016, 2069.
    • (2016) JAMA , vol.315 , pp. 2069
    • Chandra, A.1    Shafrin, J.2    Dhawan, R.3
  • 13
    • 85013572577 scopus 로고    scopus 로고
    • Available from: [Accessed June 21, 2016]
    • [13] Dalzell, M., Considerations for designing “value calculators” for oncology therapies, 2016 Available from: http://www.ajmc.com/journals/evidence-based-oncology/2016/peer-exchange-oncology-stakeholders-summit/considerations-for-designing-value-calculators-for-oncology-therapies. [Accessed June 21, 2016].
    • (2016) Considerations for designing “value calculators” for oncology therapies
    • Dalzell, M.1
  • 14
    • 85013624362 scopus 로고    scopus 로고
    • Lessons to learn from the NICE cancer care model
    • Available from: [Accessed August 2,].
    • [14] Dangi-Garimella S. Lessons to learn from the NICE cancer care model. Available from: http://www.ajmc.com/journals/evidence-based-oncology/2016/july-2016/lessons-to-learn-from-the-nice-cancer-care-model/P-1. [Accessed August 2, 2016].
    • (2016)
    • Dangi-Garimella, S.1
  • 15
    • 85013617269 scopus 로고    scopus 로고
    • Is there a mathematical resolution to the cost-versus-value debate?
    • [15] Feinberg, B., Lal, L., Swint, M., Is there a mathematical resolution to the cost-versus-value debate?. Am J Manag Care 21 (2015), SP542–SP544.
    • (2015) Am J Manag Care , vol.21 , pp. SP542-SP544
    • Feinberg, B.1    Lal, L.2    Swint, M.3
  • 16
    • 84975261142 scopus 로고    scopus 로고
    • Value: the next frontier in cancer care
    • [16] Goulart, B.H.L., Value: the next frontier in cancer care. Oncologist 21 (2016), 651–653.
    • (2016) Oncologist , vol.21 , pp. 651-653
    • Goulart, B.H.L.1
  • 17
    • 84952907922 scopus 로고    scopus 로고
    • Measuring the value of prescription drugs
    • [17] Neumann, P.J., Cohen, J.T., Measuring the value of prescription drugs. N Engl J Med 373 (2015), 2595–2597.
    • (2015) N Engl J Med , vol.373 , pp. 2595-2597
    • Neumann, P.J.1    Cohen, J.T.2
  • 18
    • 84952903757 scopus 로고    scopus 로고
    • Value-based cancer care
    • [18] Young, R.C., Value-based cancer care. N Engl J Med 373 (2015), 2593–2595.
    • (2015) N Engl J Med , vol.373 , pp. 2593-2595
    • Young, R.C.1
  • 19
    • 85013576051 scopus 로고    scopus 로고
    • Cancer facts and figures 2016. Available from: [Accessed June 21, 2016].
    • [19] American Cancer Society. Cancer facts and figures 2016. 2016. Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/. [Accessed June 21, 2016].
    • (2016)
  • 20
    • 0028600665 scopus 로고
    • Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology
    • [20] Cicchetti, D.V., Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6 (1994), 284–290.
    • (1994) Psychol Assess , vol.6 , pp. 284-290
    • Cicchetti, D.V.1
  • 21
    • 78650589643 scopus 로고    scopus 로고
    • What is value in health care?
    • [21] Porter, M.E., What is value in health care?. N Engl J Med 363 (2010), 2477–2481.
    • (2010) N Engl J Med , vol.363 , pp. 2477-2481
    • Porter, M.E.1
  • 22
    • 84981533537 scopus 로고    scopus 로고
    • Value-based care in lung cancer
    • [22] Eaton, K.D., Jagels, B., Martins, R.G., Value-based care in lung cancer. Oncologist 21 (2016), 903–906.
    • (2016) Oncologist , vol.21 , pp. 903-906
    • Eaton, K.D.1    Jagels, B.2    Martins, R.G.3
  • 24
    • 85015631371 scopus 로고    scopus 로고
    • Value-based model: a new perspective in medical decision-making
    • [24] Riva, S., Pravettoni, G., Value-based model: a new perspective in medical decision-making. Front Public Health, 4, 2016, 118.
    • (2016) Front Public Health , vol.4 , pp. 118
    • Riva, S.1    Pravettoni, G.2
  • 25
    • 85013600727 scopus 로고    scopus 로고
    • The patient voice in value: the NHC patient-centered value model rubric. Available from: [Accessed December 9, 2016].
    • [25] National Health Council. The patient voice in value: the NHC patient-centered value model rubric. 2016. Available from: http://www.nationalhealthcouncil.org/sites/default/files/Value-Rubric.pdf. [Accessed December 9, 2016].
    • (2016)
  • 26
    • 84866712708 scopus 로고    scopus 로고
    • An introduction to intraclass correlation that resolves some common confusions
    • Faculty paper, Programs in Science, Technology and Values, Critical and Creative Thinking, and Public Policy, University of Massachusetts, Boston, MA. Available from: [Accessed June 15,].
    • [26] Taylor PJ. An introduction to intraclass correlation that resolves some common confusions. Faculty paper, Programs in Science, Technology and Values, Critical and Creative Thinking, and Public Policy, University of Massachusetts, Boston, MA. Available from: http://www.faculty.umb.edu/pjt/09b.pdf. [Accessed June 15, 2016].
    • (2016)
    • Taylor, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.